Showing results (221-230 of 286) with videos related to
Sort By:
Pageof 29
Journal of Human Virology|March 22, 2002
Detection and quantification of multiple drug resistance mutations in HIV-1 reverse transcriptase by an oligonucleotide ligation assayM L Villahermosa, I Beck, L Pérez-Alvarez, et al.The Journal of Infectious Diseases|April 1, 1997
Analysis of the maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1L M Frenkel, M K Cowles, D E Shapiro, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2013
Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-infected children aged 2 through 18 yearsSharon Nachman, Nan Zheng, Edward P Acosta, et al.Plos Medicine|March 28, 2018
Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohortJoanne D Stekler, Ross Milne, Rachel Payant, et al.The Journal of Clinical Investigation|June 4, 2024
Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiationJaimy Joy, Ana Gervassi, Lennie Chen, et al.AIDS (London, England)|April 5, 2019
Minority and majority pretreatment HIV-1 drug resistance associated with failure of first-line nonnucleoside reverse-transcriptase inhibitor antiretroviral therapy in Kenyan womenRoss S Milne, Rachel A Silverman, Ingrid A Beck, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2008
Transmission cluster of multiclass highly drug-resistant HIV-1 among 9 men who have sex with men in Seattle/King County, WA, 2005-2007Susan E Buskin, Giovanina M Ellis, Gregory G Pepper, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 9, 2021
Brief Report: Vaginal Viral Shedding With Undetectable Plasma HIV Viral Load in Pregnant Women Receiving 2 Different Antiretroviral Regimens: A Randomized Clinical TrialLisa M Frenkel, R Leavitt Morrison, Trevon L Fuller, et al.AIDS (London, England)|October 28, 2022
Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapyRoss S Milne, Ingrid A Beck, Molly Levine, et al.The Journal of Infectious Diseases|October 18, 2017
Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug ResistanceHoracio A Duarte, Nuttada Panpradist, Ingrid A Beck, et al.Pageof 29